Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ALKIM.IS Stock Summary
Top 10 Correlated ETFs
ALKIM.IS
In the News
ALKIM.IS Financial details
Company Rating
Buy
Market Cap
5.04B
Income
271.07M
Revenue
4.03B
Book val./share
17.1
Cash/share
4.76
Dividend
0.93
Dividend %
2.58%
Employees
717
Optionable
No
Shortable
Yes
Earnings
07 May 2024
P/E
11.37
Forward P/E
-
PEG
-2.16
P/S
1.82
P/B
4.66
P/C
6.8
P/FCF
18.6
Quick Ratio
1.34
Current Ratio
2.22
Debt / Equity
0.04
LT Debt / Equity
-
-
-
EPS (TTM)
1.81
EPS next Y
-
EPS next Q
-
EPS this Y
-52.62%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
15.52%
Revenue last 5Y
42.24%
Revenue Q/Q
75.32%
EPS Q/Q
-162.32%
-
-
-
-
SMA20
-17.95%
SMA50
-17.95%
SMA100
-15.79%
Inst Own
-
Inst Trans
-
ROA
22%
ROE
43%
ROC
0.5%
Gross Margin
25%
Oper. Margin
23%
Profit Margin
16%
Payout
34%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
23.5-49.6
52W High
-33.92%
52W Low
+40.78%
RSI
42
Rel Volume
1.09
Avg Volume
1.31M
Volume
1.42M
Perf Week
2.53%
Perf Month
-20.44%
Perf Quarter
-15.5%
Perf Half Y
-25.56%
-
-
-
-
Beta
0.077
-
-
Volatility
0.74%, 3.4%
Prev Close
0%
Price
32.38
Change
-0.31%
ALKIM.IS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 4.61 | 5.03 | 7.31 | 18.65 | 26.84 | |
Net income per share | 0.88 | 1.33 | 1.65 | 3.82 | 1.81 | |
Operating cash flow per share | 0.95 | 0.67 | 2.43 | 1.16 | 6.37 | |
Free cash flow per share | 0.81 | 0.55 | 1.46 | 0.39 | 5.5 | |
Cash per share | 0.99 | 0.98 | 2.2 | 1.56 | 4.76 | |
Book value per share | 2.6 | 3.33 | 4.45 | 7.34 | 17.1 | |
Tangible book value per share | 2.8 | 3.58 | 4.9 | 8.3 | 18.26 | |
Share holders equity per share | 2.6 | 3.33 | 4.45 | 7.34 | 17.1 | |
Interest debt per share | 0.38 | 0.34 | 0.55 | 0.48 | 0.73 | |
Market cap | 942.52M | 2.24B | 2.53B | 5.88B | 5.11B | |
Enterprise value | 844.69M | 2.09B | 2.27B | 5.71B | 4.64B | |
P/E ratio | 7.17 | 11.22 | 10.2 | 10.27 | 18.86 | |
Price to sales ratio | 1.36 | 2.96 | 2.31 | 2.1 | 1.27 | |
POCF ratio | 6.6 | 22.21 | 6.93 | 33.86 | 5.35 | |
PFCF ratio | 7.78 | 27.32 | 11.56 | 101.24 | 6.2 | |
P/B Ratio | 2.42 | 4.48 | 3.79 | 5.34 | 1.99 | |
PTB ratio | 2.42 | 4.48 | 3.79 | 5.34 | 1.99 | |
EV to sales | 1.22 | 2.77 | 2.07 | 2.04 | 1.15 | |
Enterprise value over EBITDA | 4.46 | 8.02 | 6.04 | 6.5 | 7.37 | |
EV to operating cash flow | 5.91 | 20.76 | 6.22 | 32.89 | 4.85 | |
EV to free cash flow | 6.97 | 25.54 | 10.38 | 98.32 | 5.62 | |
Earnings yield | 0.14 | 0.09 | 0.1 | 0.1 | 0.05 | |
Free cash flow yield | 0.13 | 0.04 | 0.09 | 0.01 | 0.16 | |
Debt to equity | 0.13 | 0.09 | 0.11 | 0.06 | 0.04 | |
Debt to assets | 0.09 | 0.06 | 0.07 | 0.04 | 0.03 | |
Net debt to EBITDA | -0.52 | -0.56 | -0.69 | -0.19 | -0.75 | |
Current ratio | 3.42 | 3.54 | 2.55 | 3.27 | 2.64 | |
Interest coverage | 35.67 | 55.23 | 46.71 | 152.34 | 29.34 | |
Income quality | 1.02 | 0.47 | 1.28 | 0.26 | 3.53 | |
Dividend Yield | 0.07 | 0.01 | 0.05 | 0.02 | 0.04 | |
Payout ratio | 0.48 | 0.12 | 0.55 | 0.24 | 0.76 | |
Sales general and administrative to revenue | 0.04 | 0.04 | 0.03 | 0.02 | 0.03 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.01 | 0.01 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.15 | -0.19 | -0.4 | -0.67 | -0.14 | |
Capex to revenue | -0.03 | -0.02 | -0.13 | -0.04 | -0.03 | |
Capex to depreciation | -0.95 | -0.86 | -6.1 | -3.5 | -0.94 | |
Stock based compensation to revenue | 0.01 | 0.03 | 0 | 0 | 0.07 | |
Graham number | 7.16 | 9.97 | 12.87 | 25.1 | 26.37 | |
ROIC | 0.32 | 0.41 | 0.36 | 0.57 | 0.24 | |
Return on tangible assets | 0.24 | 0.27 | 0.22 | 0.33 | 0.08 | |
Graham Net | 1.09 | 0.88 | 1.57 | 2.77 | 4.33 | |
Working capital | 269.92M | 366.49M | 513.83M | 913.21M | 1.23B | |
Tangible asset value | 419.27M | 537.46M | 734.44M | 1.24B | 2.74B | |
Net current asset value | 251.03M | 297.68M | 432.43M | 818.73M | 1.18B | |
Invested capital | 0.13 | 0.09 | 0.11 | 0.06 | 0.04 | |
Average receivables | 110.84M | 139.67M | 204.16M | 403.7M | 499.36M | |
Average payables | 46.34M | 55.11M | 140.68M | 260.28M | 412.44M | |
Average inventory | 115.25M | 134.59M | 209.07M | 390.19M | 663.33M | |
Days sales outstanding | 64.7 | 75.88 | 83.73 | 72.54 | 40.15 | |
Days payables outstanding | 34.13 | 47.16 | 99.96 | 57.88 | 58.84 | |
Days of inventory on hand | 81.19 | 117.31 | 118.87 | 99.58 | 90.78 | |
Receivables turnover | 5.64 | 4.81 | 4.36 | 5.03 | 9.09 | |
Payables turnover | 10.69 | 7.74 | 3.65 | 6.31 | 6.2 | |
Inventory turnover | 4.5 | 3.11 | 3.07 | 3.67 | 4.02 | |
ROE | 0.34 | 0.4 | 0.37 | 0.52 | 0.11 | |
Capex per share | -0.14 | -0.13 | -0.97 | -0.77 | -0.87 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 5 | 4.19 | 5.07 | 6.39 | 11.2 | |
Net income per share | 0.79 | 0.39 | 0.9 | 1.38 | -0.86 | |
Operating cash flow per share | -0.12 | 1.29 | 1.98 | 0.16 | 2.88 | |
Free cash flow per share | -0.62 | 1.13 | 1.89 | 0.03 | 2.38 | |
Cash per share | 1.56 | 2.25 | 3.51 | 3.71 | 4.76 | |
Book value per share | 7.34 | 7.6 | 7.7 | 8.86 | 17.1 | |
Tangible book value per share | 8.3 | 8.43 | 8.73 | 10.09 | 18.26 | |
Share holders equity per share | 7.34 | 7.6 | 7.7 | 8.86 | 17.1 | |
Interest debt per share | 0.45 | 0.35 | 0.5 | 0.66 | 0.68 | |
Market cap | 5.88B | 4.74B | 4.55B | 7.05B | 5.11B | |
Enterprise value | 5.71B | 4.45B | 4.12B | 6.62B | 4.64B | |
P/E ratio | 12.36 | 20.29 | 8.4 | 8.53 | -9.87 | |
Price to sales ratio | 7.84 | 7.55 | 5.99 | 7.36 | 3.04 | |
POCF ratio | -340.44 | 24.49 | 15.3 | 292.48 | 11.85 | |
PFCF ratio | -63.07 | 27.87 | 16.02 | 1.37K | 14.34 | |
P/B Ratio | 5.34 | 4.16 | 3.94 | 5.3 | 1.99 | |
PTB ratio | 5.34 | 4.16 | 3.94 | 5.3 | 1.99 | |
EV to sales | 7.61 | 7.09 | 5.42 | 6.91 | 2.76 | |
Enterprise value over EBITDA | 33.92 | 50.79 | 18.82 | 22.44 | 34.33 | |
EV to operating cash flow | -330.62 | 23.01 | 13.86 | 274.52 | 10.75 | |
EV to free cash flow | -61.25 | 26.17 | 14.51 | 1.28K | 13.01 | |
Earnings yield | 0.02 | 0.01 | 0.03 | 0.03 | -0.03 | |
Free cash flow yield | -0.02 | 0.04 | 0.06 | 0 | 0.07 | |
Debt to equity | 0.06 | 0.05 | 0.06 | 0.07 | 0.04 | |
Debt to assets | 0.04 | 0.03 | 0.03 | 0.04 | 0.03 | |
Net debt to EBITDA | -1.01 | -3.28 | -1.95 | -1.47 | -3.5 | |
Current ratio | 3.27 | 3.18 | 2.22 | 2.42 | 2.64 | |
Interest coverage | 328 | 153.34 | 47.67 | 79.13 | 2.05 | |
Income quality | -0.13 | 3.13 | 1.79 | 0.1 | -3.33 | |
Dividend Yield | 0 | 0 | 0.03 | 0 | 0.01 | |
Payout ratio | 0 | 0.37 | 1.04 | 0 | -0.34 | |
Sales general and administrative to revenue | 0.02 | 0.04 | 0.03 | 0.03 | 0.04 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 4.4 | -0.12 | -0.04 | -0.79 | -0.17 | |
Capex to revenue | -0.1 | -0.04 | -0.02 | -0.02 | -0.04 | |
Capex to depreciation | -8.96 | -2.84 | -1.65 | -2.27 | -0.65 | |
Stock based compensation to revenue | 0.01 | -0.01 | 0 | 0 | 0.2 | |
Graham number | 11.44 | 8.16 | 12.51 | 16.58 | 18.23 | |
ROIC | 0.12 | 0.05 | 0.13 | 0.15 | 0 | |
Return on tangible assets | 0.07 | 0.03 | 0.06 | 0.09 | -0.04 | |
Graham Net | 2.77 | 3.07 | 2.61 | 3.27 | 4.33 | |
Working capital | 913.21M | 898.42M | 905.32M | 1.03B | 1.23B | |
Tangible asset value | 1.24B | 1.26B | 1.31B | 1.51B | 2.74B | |
Net current asset value | 818.73M | 829.07M | 835.21M | 975.35M | 1.18B | |
Invested capital | 0.06 | 0.05 | 0.06 | 0.07 | 0.04 | |
Average receivables | 476.34M | 519.61M | 476.11M | 519.56M | 506.54M | |
Average payables | 267.13M | 268.66M | 401.53M | 541.02M | 517.01M | |
Average inventory | 485.98M | 504.3M | 569.1M | 611.63M | 687.82M | |
Days sales outstanding | 66.74 | 69.28 | 55.51 | 53.56 | 23.72 | |
Days payables outstanding | 50.28 | 41.91 | 87.32 | 71.6 | 31.32 | |
Days of inventory on hand | 86.5 | 87.18 | 100 | 79.78 | 48.32 | |
Receivables turnover | 1.35 | 1.3 | 1.62 | 1.68 | 3.79 | |
Payables turnover | 1.79 | 2.15 | 1.03 | 1.26 | 2.87 | |
Inventory turnover | 1.04 | 1.03 | 0.9 | 1.13 | 1.86 | |
ROE | 0.11 | 0.05 | 0.12 | 0.16 | -0.05 | |
Capex per share | -0.51 | -0.16 | -0.09 | -0.13 | -0.5 |
ALKIM.IS Frequently Asked Questions
What is Alkim Alkali Kimya A.S. stock symbol ?
Alkim Alkali Kimya A.S. is a TR stock and trading under the symbol ALKIM.IS
What is Alkim Alkali Kimya A.S. stock quote today ?
Alkim Alkali Kimya A.S. stock price is $32.38 today.
Is Alkim Alkali Kimya A.S. stock public?
Yes, Alkim Alkali Kimya A.S. is a publicly traded company.